Belviq Gets FDA Nod; First New Obesity Drug in 13 Years
By Mari Serebrov
Thursday, June 28, 2012
Arena Pharmaceuticals Inc. claimed the brass ring Wednesday, scoring the FDA's first approval of a new weight-loss drug in 13 years.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.